Meibum color and free fatty acid composition in patients with meibomian gland dysfunction

Arita R., Mori N., Shirakawa R., Asai K., Imanaka T., Fukano Y., Nakamur M., Amano S.

2015
Investigative Ophthalmology and Visual Science

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Clinical development

Affiliations

Department of Ophthalmology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan; Department of Ophthalmology, Itoh Clinic, Saitama City, Saitama, Japan; Research and Development Division, Santen Pharmaceutical Co. Ltd, Kita-ku, Osaka, Japan; Inouye Eye Hospital, Chiyoda-ku, Tokyo, Japan; Miyata Eye Hospital, Miyakonojo City, Miyazaki, Japan

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.

Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.

Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022